D-0083-2018 Class II Terminated
FDA drug recall D-0083-2018 was initiated by United Therapeutics Corp. on Sep 11, 2017 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 12 devices.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 29, 2017
- Initiation Date
- Sep 11, 2017
- Termination Date
- Apr 3, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12 devices
Product description
TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601
Reason for recall
CGMP Deviations
Distribution pattern
PA
Code information
Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0083-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026